VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
68 hedge funds and large institutions have $62.3M invested in Viracta Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 22 reducing their positions, and 12 closing their positions.
Holders
68
Holders Change
–
Holders Change %
0%
% of All Funds
1.08%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
13
Reduced
22
Closed
12
Calls
$934K
Puts
$287K
Net Calls
+$647K
Net Calls Change
+$845K